US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 5,492 | 5,025 | N/A |
| Receivables | 53 | 80 | N/A |
| Inventories | 372 | 164 | N/A |
| TOTAL | $6,178 | $5,365 | $N/A |
| Non-Current Assets | |||
| PPE Net | 445 | 527 | N/A |
| Other Non-Current Assets | 4,702 | 616 | 0 |
| TOTAL | $5,146 | $1,143 | $N/A |
| Total Assets | $11,324 | $6,508 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,134 | 804 | 0 |
| Accrued Expenses | 4,512 | 701 | N/A |
| TOTAL | $13,864 | $2,161 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 2,943 | N/A | N/A |
| Deferred Revenues | 547 | 657 | N/A |
| TOTAL | $2,965 | $37 | $N/A |
| Total Liabilities | $16,829 | $2,197 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 14 | N/A | N/A |
| Common Shares | 13 | 13 | N/A |
| Retained earnings | -82,580 | -64,513 | N/A |
| TOTAL | $-5,505 | $4,311 | $N/A |
| Total Liabilities And Equity | $11,324 | $6,508 | $0 |